This is a preprint.
A Large-Scale Genome-wide Association Study of Blood Pressure Accounting for Gene-Depressive Symptomatology Interactions in 564,680 Individuals from Diverse Populations
- PMID: 40034430
- PMCID: PMC11875294
- DOI: 10.21203/rs.3.rs-6025759/v1
A Large-Scale Genome-wide Association Study of Blood Pressure Accounting for Gene-Depressive Symptomatology Interactions in 564,680 Individuals from Diverse Populations
Abstract
Background: Gene-environment interactions may enhance our understanding of hypertension. Our previous study highlighted the importance of considering psychosocial factors in gene discovery for blood pressure (BP) but was limited in statistical power and population diversity. To address these challenges, we conducted a multi-population genome-wide association study (GWAS) of BP accounting for gene-depressive symptomatology (DEPR) interactions in a larger and more diverse sample.
Results: Our study included 564,680 adults aged 18 years or older from 67 cohorts and 4 population backgrounds (African (5%), Asian (7%), European (85%), and Hispanic (3%)). We discovered seven novel gene-DEPR interaction loci for BP traits. These loci mapped to genes implicated in neurogenesis (TGFA, CASP3), lipid metabolism (ACSL1), neuronal apoptosis (CASP3), and synaptic activity (CNTN6, DBI). We also identified evidence for gene-DEPR interaction at nine known BP loci, further suggesting links between mood disturbance and BP regulation. Of the 16 identified loci, 11 loci were derived from African, Asian, or Hispanic populations. Post-GWAS analyses prioritized 36 genes, including genes involved in synaptic functions (DOCK4, MAGI2) and neuronal signaling (CCK, UGDH, SLC01A2). Integrative druggability analyses identified 11 druggable candidate gene targets, including genes implicated in pathways linked to mood disorders as well as gene products targeted by known antihypertensive drugs.
Conclusions: Our findings emphasize the importance of considering gene-DEPR interactions on BP, particularly in non-European populations. Our prioritized genes and druggable targets highlight biological pathways connecting mood disorders and hypertension and suggest opportunities for BP drug repurposing and risk factor prevention, especially in individuals with DEPR.
Figures
References
-
- Lawes CM, Vander Hoorn S, Rodgers A, International Society of H: Global burden of blood-pressure-related disease, 2001. Lancet 2008, 371:1513–1518. - PubMed
-
- Jaeger BC, Chen L, Foti K, Hardy ST, Bress AP, Kane SP, Huang L, Herrick JS, Derington CG, Poudel B, et al.: Hypertension Statistics for US Adults: An Open-Source Web Application for Analysis and Visualization of National Health and Nutrition Examination Survey Data. Hypertension 2023, 80:1311–1320. - PMC - PubMed
-
- Hunter DJ: Gene-environment interactions in human diseases. Nat Rev Genet 2005, 6:287–298. - PubMed
Publication types
Grants and funding
- R01 HL143885/HL/NHLBI NIH HHS/United States
- R01 HL163262/HL/NHLBI NIH HHS/United States
- R01 HL142302/HL/NHLBI NIH HHS/United States
- R01 HL163972/HL/NHLBI NIH HHS/United States
- R01 HL151152/HL/NHLBI NIH HHS/United States
- P01 CA196569/CA/NCI NIH HHS/United States
- R01 HG010297/HG/NHGRI NIH HHS/United States
- R01 DK122503/DK/NIDDK NIH HHS/United States
- R01 DK117445/DK/NIDDK NIH HHS/United States
- R01 HL153805/HL/NHLBI NIH HHS/United States
- R01 HL105756/HL/NHLBI NIH HHS/United States
- R01 HL118305/HL/NHLBI NIH HHS/United States
- R01 HL156991/HL/NHLBI NIH HHS/United States
- R01 HL172803/HL/NHLBI NIH HHS/United States
- R01 MD012765/MD/NIMHD NIH HHS/United States
- R01 HD057194/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
